Elsevier First to Publish NADAC Price Type from CMS

Elsevier's Gold Standard is the first drug database to include CMS's survey-based pricing, making it the most comprehensive source for drug price benchmarks

Philadelphia, PA, December 11, 2013

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that, effective November 30, 2013, the Centers for Medicare & Medicaid Services' (CMS) survey-based price type, National Average Drug Acquisition Cost (NADAC) is included for all available drugs where applicable in Elsevier's Gold Standard Drug Database and web-based solutions, ProspectoRx and RxPrice Verify.

CMS invested in NADAC, which is based on a monthly voluntary survey of randomly selected pharmacies nationwide. NADAC was created in order to provide Medicaid agencies with a better estimate of prices paid by pharmacies for drugs, which would be based upon actual drug purchases. The NADAC file is updated on a weekly basis and each month a new survey file is posted to reflect findings from the previous month's survey results. Elsevier publishes both the weekly price type file and monthly file.

"NADAC is another option for a new drug price benchmark that our customers, and the industry as a whole, may decide to use," said Kay Morgan, Vice President of Drug Products and Industry Standards, Elsevier. "We at Elsevier strive to provide the most accurate and continuously updated data for our users."

Elsevier's Gold Standard Drug Database pricing file is the only compendia that continues to publish Average Wholesale Price (AWP), along with several other price types: Wholesale Acquisition Cost (WAC), Direct Price (DP), Federal Supply Schedule (FSS), CMS Federal Upper Limit (CMS-FUL), Maximum Allowable Cost (MAC), and Predictive Acquisition Cost (PAC). Elsevier's drug pricing database delivers the most up-to-the-minute data available via web-based solutions, ProspectoRx and RxPrice Verify.

For more information about Elsevier's Gold Standard, visit www.goldstandard.com.

# # #

About Elsevier
Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a world-leading provider of information and analytics to professionals and business customers, in a wide range of industries. www.elsevier.com

Media contact
Christopher Capot
Director, Corporate Relations, Elsevier
+1 212 633 3164
c.capot@elsevier.com